Brief: Oncocyte Files For Resale Of Up To 5.42 Mln Common Shares By Selling Stockholders
May 10 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE CORP FILES FOR RESALE OF UP TO 5.42 MILLION
COMMON
SHARES BY THE SELLING STOCKHOLDERS - SEC FILING
Source text for Eikon: ID:n0001493152-24-018709
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission